BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Earnings
Onconova Therapeutics Inc. (ONTX) Reports Recent Business Highlights And Fourth Quarter And Year-End 2014 Financial Results 3/27/2015
Calithera Biosciences, Inc. (CALA) Reports Fourth Quarter And Full Year 2014 Financial Results And Recent Highlights 3/27/2015
Agile Therapeutics, Inc. Reports Fourth Quarter And Full Year 2014 Financial Results 3/27/2015
Loxo Oncology (LOXO) Announces Fourth Quarter And Year-End 2014 Financial Results 3/27/2015
Heat Biologics Announces Financial Results For The Year Ended December 31, 2014 3/27/2015
CASI Pharmaceuticals  (CASI) Reports 2014 Fourth Quarter And Full Year Financial Results 3/27/2015
OncoGenex Pharmaceuticals Inc. (OGXI) Reports Financial Results For Fourth Quarter And Year End 2014 3/27/2015
Midatech Pharma PLC: Notice Of Maiden Preliminary Results 3/26/2015
Ascendis Pharma A/S Reports Full Year 2014 Financial Results 3/26/2015
BrainStorm Cell Therapeutics Inc. Announces Financial Results For 2014 And Provides Business Update 3/26/2015
Neogen Corporation (NEOG) Reports 13% Increase In Net Income 3/26/2015
Celladon Corporation To Report Fourth Quarter And Fiscal 2014 Results On March 31 3/26/2015
Titan Pharmaceuticals (TTP) Schedules Conference Call To Review Fourth Quarter And Full Year 2014 Financial Results 3/26/2015
Zosano Pharma, Inc. Reports 2014 Financial Results 3/26/2015
Ultragenyx Pharmaceuticals (RARE) Reports Fourth Quarter And Full-Year 2014 Financial Results And Corporate Update 3/26/2015
Dermira Reports Fourth Quarter And Full Year 2014 Financial Results And Provides Corporate Update 3/26/2015
Emisphere Technologies, Inc. (EMIS) Announces Fourth Quarter and Full Year 2014 Financial Results Conference Call 3/26/2015
Kite Pharma (KITE) To Report Fourth Quarter And Full Year 2014 Financial Results On March 26th, 2015 3/26/2015
Cardio3 BioSciences Reports 2014 Financial And Operating Results 3/26/2015
NovaBay Pharmaceuticals, Inc. (NBY) Reports 2014 Fourth Quarter And Full Year Financial Results And Provides Business Update 3/26/2015
AngioDynamics (ANGO) To Report Fiscal 2015 Third Quarter Financial Results 3/26/2015
Neothetics Reports Fourth Quarter and Full Year 2014 Financial Results 3/26/2015
Kite Pharma (KITE) Reports Full-Year and Fourth Quarter 2014 Financial Results 3/26/2015
Epigenomics AG Reports Results For The Financial Year Ended December 31, 2014 And Provides Outlook For 2015 3/25/2015
Amphastar Pharmaceuticals, Inc. (AMPH) Reports Revenues Of $55.9 Million For The Fourth Quarter Ended December 31, 2014 3/25/2015
Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Fourth Quarter And Full Year 2014 Financial Results 3/25/2015
Cellectar Biosciences  (NVLT) Full-Year 2014 Financial Results And Recent Highlights 3/25/2015
DBV Technologies Reports Full Year 2014 Financial Results 3/25/2015
VBL Therapeutics (VBLX) Announces Fourth Quarter And Full Year 2014 Financial Results 3/25/2015
Affimed Therapeutics AG (AFMD) Announces Financial Results For Fourth Quarter And Year End 2014 3/25/2015
Recro Pharma (REPH) Reports Fourth Quarter And Full Year 2014 Financial Results 3/25/2015
Nuo Therapeutics To Hold Fourth Quarter And Full Year 2014 Conference Call On Wednesday, April 1 At 8:00 A.M. Eastern Time 3/25/2015
Forward Pharma (FWP) Reports Fourth Quarter And Year End 2014 Financial And Operational Results 3/25/2015
TRANSGENE (ENX:TNG) Reports 2014 Financial Results And Outlines Promising Clinical Pipeline 3/25/2015
NephroGenex (NRX) Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2014 3/25/2015
MediGene AG (MDGEF.PK) Publishes Final Financials 2014: Significant Improvement In Revenue, EBITDA And Net Result 3/25/2015
Orexo AB (ORXOF)’s Annual Report for 2014 Released 3/25/2015
Coherus Biosciences Reports Fourth Quarter And Year End 2014 Financial And Operating Results 3/24/2015
Vericel (ASTM) Reports Fourth-Quarter And Year-End 2014 Financial Results 3/24/2015
Flexion Therapeutics (FLXN) Reports Year-End 2014 Financial Results 3/24/2015
EPIRUS Biopharmaceuticals Reports Fourth Quarter And Fiscal Year 2014 Financial Results 3/24/2015
Horizon Discovery Group Plc Release: Notice Of Preliminary Results 3/24/2015
CytoSorbents, Inc. To Report Fiscal 2014 Operating And Financial Results 3/24/2015
Soligenix (SNGX) Announces Recent Accomplishments And Year-End 2014 Financial Results 3/24/2015
GenVec Inc. (GNVC) Reports Fourth Quarter And 2014 Year-End Financial Results 3/24/2015
Galmed Pharmaceuticals Fourth Quarter 2014 Conference Call and Webcast Scheduled for Tuesday, March 31, 2015 3/24/2015
Skyepharma PLC (SKYEF) Preliminary Announcement Of 2014 Annual Results 3/24/2015
Evotec AG (EVTG.F) FY 2014: Strong Performance In EVT Execute And Acceleration Of EVT Innovate 3/24/2015
Dipexium Pharmaceuticals (DPRX) Reports 2014 Financial Results 3/24/2015
Mast Therapeutics (MSTX) Reports Fourth Quarter And Full Year 2014 Financial Results 3/24/2015
OncoGenex Pharmaceuticals Inc. (OGXI) To Report Financial Results For Fourth Quarter And Year End 2014 On March 26, 2015 3/23/2015
IntelGenx Corp. To Report 2014 Annual Results And Provide Corporate Development Update On March 31, 2015 3/23/2015
Ultragenyx Pharmaceuticals (RARE) To Host Conference Call For Fourth Quarter And Full-Year 2014 Financial Results And Corporate Update 3/23/2015
Deltagen (DGEN) Reports 2014 Full Year Financial Results 3/23/2015
Cardio3 BioSciences Announces Details Of Upcoming Full-Year 2014 Financial Results 3/23/2015
GeoVax Labs Inc. (GOVX.OB) Reports 2014 Year-End Financial Results 3/23/2015
BioLineRx Ltd. Reports Year End 2014 Financial Results 3/23/2015
Zafgen (ZFGN) Reports Fourth Quarter And Full Year 2014 Financial Results 3/20/2015
Vital Therapies, Inc. (VTI) (VTL) Announces Fourth Quarter And Full Year 2014 Financial Results And Provides A Corporate Update 3/20/2015
Metabolix, Inc. Announces Fourth Quarter And Full Year 2014 Financial Results 3/20/2015
VBL Therapeutics (VBLX) To Report Fourth Quarter And Full Year 2014 Financial Results On March 25, 2015 3/20/2015
Minerva Neurosciences, Inc. (NERV) To Host Fourth Quarter And Full Year 2014 Financial Results Webcast And Conference Call 3/20/2015
Kythera (KYTH) Announces 2015 Outlook Call 3/20/2015
Proteon Therapeutics, Inc. (PRTO) Announces Fourth Quarter And Full-Year 2014 Financial Results 3/20/2015
Calithera Biosciences, Inc. (CALA) To Report Fourth Quarter And Year-End 2014 Financial Results On Thursday, March 26, 2015 3/20/2015
Hemispherx Biopharma (HEB) Announces Financial Results For The Year Ended December 31, 2014 3/20/2015
BrainStorm Cell Therapeutics Inc. To Report Fourth Quarter And Full Year 2014 Financial Results On Thursday, March 26 3/20/2015
Concordia Healthcare (CXR.TO) Announces Fourth Quarter and Fiscal 2014 Results 3/20/2015
FibroGen, Inc. (FGEN) To Report Fourth Quarter And Full Year 2014 Financial Results On March 26, 2015 3/20/2015
Enumeral Biomedical (ENUM) Reports Fourth Quarter And Year-End 2014 Financial Results 3/20/2015
Interleukin Genetics Inc. (ILGN) Reports Fourth Quarter And Year-End 2014 Financial Results 3/20/2015
Cerulean Pharma Inc. (CERU) Reports Fourth Quarter 2014 Corporate Highlights And Financial Results 3/20/2015
Flamel Technologies (FLML) Announces Fourth Quarter And Full Year Results Of Fiscal Year 2014 3/20/2015
Juno Therapeutics (JUNO) Falls as Company Projects Up to $150 Million Cash Burn in First Post-IPO Earnings Report 3/19/2015
Aldeyra Therapeutics (ALDX) Reports Full Year 2014 Financial Results 3/19/2015
Cara Therapeutics, Inc. (CARA) To Announce Fourth Quarter And Full Year 2014 Financial Results On March 26, 2015 3/19/2015
Innocoll, Inc. (INNL) Announces Fourth Quarter and Full Year 2014 Financial And Operating Results 3/19/2015
Galectin Therapeutics Reports 2014 Financial Results, Provides Business Update 3/19/2015
Dermira To Report Fourth Quarter And Full Year 2014 Financial Results 3/19/2015
Capricor Therapeutics, Inc. Reports Fourth Quarter And Full Year 2014 Financial & Business Highlights 3/19/2015
Otonomy, Inc. (OTIC) Reports Fourth Quarter And Full Year 2014 Financial Results And Provides Corporate Update 3/19/2015
Nevro Corp Reports Fourth Quarter And Full Year 2014 Financial Results 3/19/2015
Auris Medical AG (EARS) Reports Fourth Quarter And Full Year 2014 Financial Results And Provides Business Update 3/19/2015
Clinical Data Of MediGene AG (MDGEF.PK)'s Dendritic Cell Vaccines To Be Presented At American Association for Cancer Research Conference 3/19/2015
Harvard Apparatus Regenerative Technology Reports Operating Results For The Fourth Quarter And Year Ended December 31, 2014 3/19/2015
Affimed Therapeutics AG (AFMD) Announces Fourth Quarter And Year End 2014 Financial Results Conference Call 3/18/2015
Macrocure (MCUR) Provides Corporate Update And Reports Fourth Quarter And Full Year 2014 Financial Results 3/18/2015
Cyclacel Pharmaceuticals, Inc. (CYCC) To Release Fourth Quarter And Full Year 2014 Financial Results 3/18/2015
OXiGENE (OXGN) Reports Financial Results For 2014 3/18/2015
Five Prime Therapeutics, Inc. (FPRX) Announces Fourth Quarter And Full Year 2014 Financial Result 3/18/2015
Amphastar Pharmaceuticals, Inc. (AMPH) To Release Fourth Quarter Earnings And Hold Conference Call On March 24, 2015 3/18/2015
Foamix Pharmaceuticals, Ltd. (FOMX) Reports Financial Results For The Year Ended December 31, 2014 3/18/2015
Spark Therapeutics (ONCE) Reports Full Year 2014 Financial Results 3/18/2015
Celator Pharmaceuticals, Inc. Announces Business Update And Fourth Quarter And Full Year 2014 Financial Results 3/18/2015
AEterna Zentaris (AEZS) Reports Fourth Quarter And Full-Year 2014 Financial And Operating Results 3/18/2015
Ascendis Pharma A/S To Report Full Year 2014 Financial Results And Host Conference Call On March 25, 2015 3/18/2015
Akorn, Inc. (AKN) Files Annual Report On Form 10-K For Year Ended December 31, 2014; Restates Second And Third Quarter 2014 Financial Statements 3/18/2015
Columbia Laboratories, Inc. (CBRX) Reports Fourth Quarter And Full-Year 2014 Financial Results 3/18/2015
Dipexium Pharmaceuticals (DPRX) To Hold Year End 2014 Financial Results Conference Call On Tuesday, March 24, 2015, 8:30 A.M. ET 3/18/2015
Trevena, Inc. (TRVN) Reports Full Year 2014 Financial Results 3/18/2015
Ignyta (RXDX) Announces 2014 Full Year Company Highlights And Financial Results 3/18/2015
Cynapsus Therapeutics (CYNAF) Reports 2014 Annual Results 3/18/2015
Tenax Therapeutics (TENX) Announces Third Quarter Fiscal Year 2015 Financial Results 3/18/2015
Auspex Pharmaceuticals (ASPX) Reports Fourth Quarter 2014 Results And Business Highlights 3/17/2015
Flexion Therapeutics (FLXN) To Report Year-End 2014 Earnings Results On March 23, 2015 3/17/2015
StemCells (STEM) Reports Fourth Quarter And Full Year 2014 Financial Results And Provides Business Update 3/17/2015
Achaogen (AKAO) Announces Fourth Quarter And Full Year 2014 Results 3/17/2015
Aquinox Pharmaceuticals (AQXP) Announces Year End 2014 Financial Results 3/17/2015
Argos Therapeutics, Inc. (ARGS) To Hold Fourth Quarter And Year-End 2014 Financial Results Conference Call On Monday, March 30, 2015 3/17/2015
TiGenix Reports Its Full Year 2014 Results 3/17/2015
Cellectar Biosciences  (NVLT) To Host Conference Call On March 24th To Discuss Fourth Quarter And Full Year 2014 Results And Provide Update On Development Progress 3/17/2015
Rexahn Pharmaceuticals, Inc. (RNN) Reports Fourth Quarter And Full-Year 2014 Financial Results And Pipeline Update 3/17/2015
Evotec AG (EVTG.F): Fiscal Year 2014 Results Presentation On 24 March 2015 3/17/2015
BioLineRx Ltd. To Report Fourth Quarter And Year End 2014 Results On March 23, 2015 3/17/2015
BioDelivery Sciences International (BDSI) Provides Corporate Update And Reports Fourth Quarter And Year-End 2014 Financial Results 3/17/2015
Emdeon Corporation (HLTH) Reports Fourth Quarter and Full Year 2014 Results 3/17/2015
Omeros Corporation (OMER) Reports Fourth Quarter And Year-End 2014 Financial Results 3/17/2015
Oncolytics Biotech Inc. (ONC.TO) Announces 2014 Year End Results 3/17/2015
Discovery Laboratories (DSCO) Reports Fourth Quarter 2014 Financial Results And Provides Update On SURFAXIN (lucinactant) Intratracheal Suspension And AEROSURF Program 3/17/2015
GlobeImmune, Inc. (GBIM) Announces Program Updates And Financial Results For Full Year 2014 3/17/2015
China Pharma Holdings, Inc. (CPHI.OB) To Hold Fiscal Year 2014 Earnings Conference Call On Tuesday, March 31, 2015 At 8:30 A.M. ET 3/17/2015
GenVec Inc. (GNVC) To Release Fourth Quarter And Year-End 2014 Financial Results And Conduct A Conference Call On March 24, 2015 3/17/2015
Champions Oncology, Inc. (CSBR) Reports Results For The Third Quarter Ended January 31, 2015 3/17/2015
Johnson & Johnson (JNJ) To Host Investor Conference Call On First-Quarter Results 3/17/2015
OvaScience (OVAS) Reports Fourth Quarter And Year End 2014 Financial Results 3/17/2015
La Jolla Pharmaceutical Company (LJPC) Announces Fourth Quarter And Full Year 2014 Financial Results And Corporate Highlights 3/17/2015
GlycoMimetics, Inc. (GLYC) Reports Fourth Quarter And Year-End 2014 Results 3/17/2015
Synergy Pharmaceuticals Reports 2014 Fourth Quarter And Full-Year Financial Results 3/17/2015
Flex Pharma (FLKS) Reports Year End 2014 Financial Results 3/17/2015
Bio-Path Holdings, Inc. (BPTH) Reports Fiscal Year 2014 Operational And Financial Results 3/17/2015
Aradigm Corporation (ARDM) Announces Fourth Quarter 2014 And Full Year Financial Results 3/17/2015
Innocoll, Inc. (INNL) To Report Fourth Quarter And Full Year 2014 Financial Results And Host Webcast And Conference Call On March 19, 2015 3/16/2015
Stemline Therapeutics, Inc. (STML) Reports Fourth Quarter 2014 Financial Results 3/16/2015
Inovio Pharmaceuticals (INO) Reports 2014 Fourth Quarter And Year End Financial Results 3/16/2015
Apricus Biosciences (APRI) Provides Corporate Update And 2014 Year-End Financial Results 3/16/2015
Karyopharm Therapeutics (KPTI) Reports Fourth Quarter And Full Year 2014 Financial Results And Highlights Recent Progress 3/16/2015
Coronado Biosciences (CNDO) Reports Financial Results For The Fourth Quarter And Year Ended December 31, 201 3/16/2015
Progenics Pharmaceuticals, Inc. (PGNX) Announces Fourth Quarter And Year-End 2014 Financial Results 3/16/2015
Catalyst Pharmaceuticals (CPRX) Announces Fourth Quarter And Year-End 2014 Financial Results 3/16/2015
Coherus Biosciences To Report Fourth Quarter And Year End 2014 Financial Results On March 23 3/16/2015
Repros Therapeutics Inc. (RPRX) Reports Fourth Quarter And Year End 2014 Financial Results 3/16/2015
Champions Oncology, Inc. (CSBR) To Announce Third Quarter Financial Results On Tuesday, March 17 3/16/2015
Synthetic Biologics Reports Year End 2014 Financial Results And Operational Highlights 3/16/2015
RXi Pharmaceuticals (RXII) To Webcast Fourth Quarter And Year End 2014 Financial Results On Monday, March 30, 2015 3/16/2015
NeuralStem Inc. Reports Fiscal 2014 Fourth Quarter Financial And Year-End Business Results 3/16/2015
Egalet Reports Full Year 2014 Financial Results 3/16/2015
Anthera Pharmaceuticals, Inc. (ANTH) Reports 2014 Fourth Quarter And Fiscal Year Financial Results, Operational Update And Recent Event Highlights 3/16/2015
Pfenex (PFNX) Reports Fourth Quarter And Full Year 2014 Results And Provides Business Update 3/16/2015
PAREXEL International (PRXL) Announces Date Of Third Quarter Fiscal Year 2015 Earnings Release And Conference Call 3/16/2015
Sorin Group S.p.A. (SRN) Announces Final Financial Results For 2014 3/16/2015
Auris Medical AG (EARS) To Announce Fourth Quarter And Full Year 2014 Financial Results And Host Conference Call On Thursday, March 19, 2015 3/16/2015
Lifeline BioTechnologies, Inc. (LBTN.PK) Q1 2015 Update 3/16/2015
Dicerna (DRNA) Announces Fourth Quarter And Full Year 2014 Financial And Operational Results 3/13/2015
Tekmira (TKMR) Provides Corporate Update And Announces Year-End 2014 Results 3/13/2015
Peregrine Pharmaceuticals, Inc. (PPHM) Reports Third Quarter Fiscal Year 2015 Financial Results And Recent Developments 3/13/2015
Marinus Pharmaceuticals (MRNS) Provides Business Update And Reports Year End 2014 Financial Results 3/13/2015
Xenon Pharmaceuticals Inc. Reports 2014 Financial Results And Provides Corporate Update 3/13/2015
OncoMed Pharmaceuticals, Inc. (OMED) Reports Full Year And Fourth Quarter 2014 Financial Results And Recent Highlights 3/13/2015
ChemoCentryx, Inc. (CCXI) Reports Fourth Quarter 2014 Financial Results And Provides Corporate Update 3/13/2015
Athersys, Inc. (ATHX) Reports Fourth Quarter And 2014 Annual Results 3/13/2015
Protalix Biotherapeutics, Inc. (PLX) Reports Full Year 2014 Financial Results And Provides Corporate Update 3/13/2015
Vericel (ASTM) To Host Fourth-Quarter 2014 Earnings Call On March 23, 2015 3/13/2015
Repligen Corporation (RGEN) Reports Financial Results For The Year 2014 And Issues 2015 Financial Guidance 3/13/2015
Fibrocell Science, Inc. Reports Fourth Quarter And Full Year 2014 Financial And Operating Results 3/13/2015
ZS Pharma (ZSPH) Reports Fourth Quarter And Year-End 2014 Financial Results And Provides ZS-9 Program Update 3/13/2015
Zafgen (ZFGN) To Host Conference Call To Discuss Fourth Quarter And Full Year 2014 Financial Results 3/13/2015
Nexvet Reports Financial Results For Second Quarter Of Fiscal Year 2015 3/13/2015
Rock Creek Pharmaceuticals Files 2014 Annual Report And Provides Clinical Development Update 3/13/2015
Kindred Bio (KIN) Announces Fourth Quarter And Year-End 2014 Financial Results 3/13/2015
CTI BioPharma Reports Fourth Quarter And Full Year 2014 Financial Results 3/13/2015
Imprimis Pharmaceuticals (immy) Announces Fourth Quarter And Year-End 2014 Financial Results And Provides Business Update 3/13/2015
Aratana Therapeutics (PETX) Reports Fourth Quarter And Full Year 2014 Results 3/13/2015
BioSpecifics Technologies Corporation (BSTC) Reports Fourth Quarter And Full Year 2014 Financial Results 3/13/2015
Oxford BioMedica PLC (OXB.L): Preliminary Results For The Year Ended 31 December 2014 3/13/2015
Anacor Pharmaceuticals, Inc. (ANAC) Reports 2014 Fourth Quarter And Year-End Financial Results 3/13/2015
Enzo Biochem (ENZ) Reports Fiscal Second Quarter Results 3/13/2015
Cytori Therapeutics, Inc. (CYTX) Reports Fourth Quarter And Full Year 2014 Business And Financial Results 3/13/2015
Heron Therapeutics, Inc. (APPA) Announces Fourth Quarter And Full Year 2014 Financial Results And Corporate Progress 3/13/2015
Luna Innovations Inc. Reports Fourth Quarter And Full Year 2014 Financial Results 3/13/2015
Discovery Laboratories (DSCO) To Hold Conference Call On Tuesday March 17, 2015 To Discuss Fourth Quarter 2014 Financial Results And Other Business Updates 3/13/2015
Conatus Pharmaceuticals Inc. Reports 2014 Financial Results And Program Updates 3/12/2015
Ocera Therapeutics, Inc. (OCRX) Reports Fourth Quarter And Full Year 2014 Financial Results 3/12/2015
XOMA (US) LLC (XOMA) Highlights Recent Achievements And Reports Fourth Quarter And Full-Year 2014 Financial Results 3/12/2015
Relypsa, Inc. (RLYP) Announces Fourth Quarter And Full Year 2014 Financial Results 3/12/2015
TG Therapeutics, Inc. (MHA) Announces Fourth Quarter And Year-End 2014 Financial Results And Business Update 3/12/2015
Sunesis Pharmaceuticals, Inc. (SNSS) Reports Fourth Quarter And Full-Year 2014 Financial Results And Recent Highlights 3/12/2015
Intra-Cellular Therapies, Inc. Reports Fourth Quarter And Full-Year 2014 Financial Results And Provides Corporate Update 3/12/2015
Otonomy, Inc. (OTIC) To Report Fourth Quarter And Full Year 2014 Financial Results And Provide Corporate Update 3/12/2015
Capricor Therapeutics, Inc. To Hold Fourth Quarter 2014 Business Update Conference Call On March 18, 2015 At 4:30 P.M. EDT 3/12/2015
Idera Pharmaceuticals, Inc. (IDRA) Reports Fourth Quarter And Year End 2014 Financial Results And Provides Corporate Update 3/12/2015
Cardiome Pharma Corp. (COM.TO) Reports Fourth Quarter And Full Year 2014 Financial Results 3/12/2015
DATATRAK International, Inc. (DATA) Reports Fourth Quarter And Full Year Results Of 2014 3/12/2015
Dyadic International, Inc. Reports 2014 Year End Financial Results 3/12/2015
Celsion Corporation (CLSN) Reports Year End 2014 Financial Results And Provides Business Update 3/12/2015
diaDexus Reports Fourth Quarter And Full Year 2014 Financial Results 3/12/2015
SciClone Pharmaceuticals, Inc. (SCLN) Reports 2014 Financial Results And 2015 Outlook 3/12/2015
Bellicum (BLCM) Provides Operational Update And Reports Financial Results For Fourth Quarter And Year Ended December 31, 2014 3/12/2015
InVivo Therapeutics Corporation (NVIV) Reports 2014 Year End Financial Results And Business Update 3/12/2015
Synta Pharmaceuticals (SNTA) Reports Fourth Quarter And Year-End 2014 Financial Results 3/12/2015
Epizyme (EPZM) Announces 2014 Financial Results And Provides Corporate Update 3/12/2015